<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="fentanyl, with concomitant increasing injection of stimulants including cocaine and" exact="methamphetamine" post="[1–3]. As a result, the incidence of injection drug"/>
 <result pre="and soft tissue infections, is rising [2, 4–11]. Injection of" exact="fentanyl" post="or heroin alone and in combination with stimulants have"/>
 <result pre="are 3 Food and Drug Administration-approved MOUDs—methadone, buprenorphine, and extended-release" exact="naltrexone" post="(XR-NTX). Methadone is a full opioid agonist and buprenorphine"/>
 <result pre="extended-release naltrexone (XR-NTX). Methadone is a full opioid agonist and" exact="buprenorphine" post="is a partial opioid agonist, while XR-NTX is an"/>
 <result pre="craving, overdose, and HIV and HCV transmission [14, 15]; and" exact="buprenorphine" post="and XR-NTX also improve HIV viral suppression in people"/>
 <result pre="reduced transmission [16, 17]. Of the 3 MOUDs, access to" exact="methadone" post="and buprenorphine are limited by regulations. Prescribing requires special"/>
 <result pre="[16, 17]. Of the 3 MOUDs, access to methadone and" exact="buprenorphine" post="are limited by regulations. Prescribing requires special training outside"/>
 <result pre="waiver from the Drug Enforcement Agency in the case of" exact="buprenorphine" post="or treatment in a federally certified opioid treatment program"/>
 <result pre="about 5% of the nation’s physicians have waivers to prescribe" exact="buprenorphine" post="and most substance use treatment programs do not have"/>
 <result pre="treatment programs do not have opioid treatment programs, which makes" exact="methadone" post="treatment challenging to obtain [18]. Therefore, the prevailing care"/>
 <result pre="of MOUDs, and for cotreatment of related infections. 7. Eliminate the" exact="buprenorphine" post="waiver, remove patient caps, and offer grant funding for"/>
 <result pre="the requirement for clinicians to obtain a waiver to prescribe" exact="buprenorphine" post="[24]. As outlined in this paper, urgent policy action"/>
 <result pre="infections. One innovative care model combined outpatient parenteral therapy with" exact="buprenorphine" post="treatment and showed similar clinical and drug use outcomes"/>
 <result pre="identified as a major barrier preventing some physicians from integrating" exact="buprenorphine" post="into their practice for the treatment of OUD [49]."/>
 <result pre="use disorder treatment https://www.projectshout.org In addition, a reorganization of the" exact="buprenorphine" post="prescribing system is needed. In order to increase the"/>
 <result pre="prescribe MOUD and improve patient access, we recommend eliminating the" exact="buprenorphine" post="waiver requirement, removing the patient caps, and dedicating grant"/>
 <result pre="B. reports providing waiver training courses for providers to become" exact="buprenorphine" post="prescribers through the Providers Clinical Support System. A. W."/>
 <result pre="Cochrane Database Syst Rev2011; (8):CD004145. 16.SpringerSA, QiuJ, Saber-TehraniAS, AlticeFLRetention on" exact="buprenorphine" post="is associated with high levels of maximal viral suppression"/>
 <result pre="prisoners. PLoS One2012; 7:e38335.22719814 17.SpringerSA, Di PaolaA, AzarMM, et al.Extended-release" exact="naltrexone" post="improves viral suppression among incarcerated persons living with HIV"/>
 <result pre="376:367–87.20650518 48.FanucchiLC, WalshSL, ThorntonAC, NuzzoPA, LofwallMROutpatient parenteral antimicrobial therapy plus" exact="buprenorphine" post="for opioid use disorder and severe injection-related infections [published"/>
</results>
